Tissuecypher® barrett's esophagus test outperformed standard of care in risk-stratifying patients with barrett's esophagus

Friendswood, texas--(business wire)---- $cstl #ai--study shows tissuecypher outperformed pathology review in predicting progression to high-grade dysplasia or esophageal cancer in barrett's patients.

CSTL Ratings Summary

CSTL Quant Ranking